Jeffrey K. Tong

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jeffrey Finer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey K. Tong:

Form 4 holding Director, 10%+ Owner

Nurix Therapeutics, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
17,500
Estimated value
Report date
06 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Septerna, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
16,623
Estimated value
Report date
17 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jeffrey K. Tong

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .